Transaction · 0001971702-26-000017

Wai Conrad

Wai Conrad, CEO, CH, reported an open-market or private sale at CLOVER HEALTH INVESTMENTS, CORP. DE involving 300000.000000 shares for an estimated $1416000.00. Reported holdings after the transaction were 1170056.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCEO, CH
CLOVCLOVER HEALTH INVESTMENTS, CORP. DE
Trade date
Sep 15, 2026
Filing date
Sep 16, 2026
View on SEC Insider profile
Disclosed value-$1.41MShares × reported price
Shares traded300k$4.72 per share
Holdings after1.17MIndirect · By Trust.
% of reported position traded20.41%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,470,056 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

CLOV price since this filing

Daily closing prices, with the filing date and available return windows
CLOV · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +0.9%1w ago -5.7%1d ago +11.9%
Returns since7d +0.4%30d -1.5%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001971702-26-000017
Class A Common Stock
Transaction date
Sep 15, 2026
Filed Sep 16, 2026, 08:27 PM · 1d delay
Shares
300,000 sh
$4.72 per share
Estimated value
-$1.41M
Computed from shares × price
Holdings after
1,170,056 sh
Indirect · By Trust.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Large Holdings Reduction Large Sale 10b5-1 Detected
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO, Counterpart Health

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2026. The price reported in Column 4 is a weighted average price. These…

  2. F2

    Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.

Original filing · 0001971702-26-000017
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

CLOV